Basilea-Logo.jpg
Basilea übertrifft bei vorläufigen Umsatzzahlen und der Cash-Position zum Jahresende die Prognosen für 2021
January 10, 2022 01:15 ET | Basilea Pharmaceutica AG
Gesamtumsatz von CHF 148 Mio. übertrifft aufgrund 65 %igem Anstieg der direkt realisierten Cresemba- und Zevtera-Umsatzbeiträge die Finanzprognose für 2021CHF 150 Mio. liquide Mittel und Finanzanlagen...
Basilea-Logo.jpg
Strong Cresemba® (isavuconazole) sales by Astellas in the U.S. trigger CHF 15 million sales milestone payment to Basilea
January 07, 2022 01:15 ET | Basilea Pharmaceutica AG
Ad hoc announcement pursuant to Art. 53 LR Basel, Switzerland, January 07, 2022 Basilea Pharmaceutica Ltd. (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs...
Basilea-Logo.jpg
Starke Cresemba® (Isavuconazol) Umsätze von Astellas in den USA lösen CHF 15 Mio. Meilensteinzahlung an Basilea aus
January 07, 2022 01:15 ET | Basilea Pharmaceutica AG
Ad hoc-Mitteilung gemäss Art. 53 KR Basel, 07. Januar 2022 Basilea Pharmaceutica AG (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel, Patienten zu...
Basilea-Logo.jpg
Basilea reports on portfolio progress made in 2021
January 06, 2022 01:15 ET | Basilea Pharmaceutica AG
Achieved important Cresemba® (isavuconazole) and Zevtera® (ceftobiprole) milestones Added new clinical candidate BAL0891 to oncology pipeline and advanced clinical programs with derazantinib and...
Basilea-Logo.jpg
Basilea berichtet über die im Jahr 2021 erzielten Fortschritte im Portfolio
January 06, 2022 01:15 ET | Basilea Pharmaceutica AG
Erreichen wichtiger Meilensteine bei Cresemba® (Isavuconazol) und Zevtera® (Ceftobiprol) Erweiterung der Onkologie-Pipeline um den neuen klinischen Kandidaten BAL0891 und Fortschritte in den...
LOGO.png
Draganfly Unveils Latest Vital Intelligence Smart Vital Kiosk During CES
January 05, 2022 07:45 ET | Draganfly Inc
Las Vegas, Nevada., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and...
LOGO.png
Draganfly to Be Featured at EDGE22: Government Technology - Common Missions in Today's Digital World Conference
January 04, 2022 08:00 ET | Draganfly Inc
Las Vegas, Nevada., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly'' or the “Company”), an award-winning, industry-leading drone solutions and...
Cornerstone-Logo-694x224.jpg
Ecuador Constitutional Court Reaffirms Revocation of the Environmental Permit for Early Stage Exploration at the Rio  Magdalena Project within the ENAMI EP Strategic Exploration Alliance in NW Ecuador
January 03, 2022 18:14 ET | Cornerstone Capital Resources Inc.
OTTAWA, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Cornerstone Capital Resources Inc. (“Cornerstone” or “the Company”) (TSXV:CGP) (OTC:CTNXF) (FWB:GWN1) announces that, further to its news release dated...
LOGO.png
Renowned Podcast Dawn of Drones To Feature Draganfly
January 03, 2022 07:30 ET | Draganfly Inc
Los Angeles, CA., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and...
LOGO.png
Draganfly Selected to Implement Health and Safety Program to Keep Events Safe During CES® 2022
December 30, 2021 07:45 ET | Draganfly Inc
Draganfly’s Vital Intelligence platform continues to provide seamless and non-invasive solutions that are helping organizations host safe events and gatherings Los Angeles, CA., Dec. 30, 2021 ...